In addition, the two BRD4 isoforms have antagonistic roles in tumour progression and metastasis in breast cancer where BRD4-S functions as an oncogene, while BRD4-L acts as a tumour suppressor (Wu et al, 2020; Alsarraj et al, 2011). Here, BRD4 is linked to breast carcinoma.